Novartis' PDUFA date is May 2019While approval may not have a significant impact on Novartis' price, a patterns suggests there may be money to be made on Ionis' stock The time is drawing nearer to … [Read more...] about PDUFA Watch: Novartis’ Zolgensma (AVXS-101)
The summer oncology conferences are drawing nearer, and so to is the abstract release date for ASCO. For a complete overview of the timeline and abstract titles I am watching, check out my previous … [Read more...] about ALERT: This Stock Has Been Beat Up, But Could Jump at ASCO
Verastem (VSTM) reported earnings on May 9th after the close of the American market and proceeded to plunge 28% during Friday's trading session. What was the cause of this selloff? Here are three big … [Read more...] about Verastem’s Earnings: Is It a Buy Now?
One of the most heralded oncology conferences is the annual American Society of Clinical Oncologists (ASCO). This year, Chicago is hosting the annual conference, which is running from May 31st through … [Read more...] about ASCO Alert: Stay Ahead of the Updates
Array Biopharma (ARRY) will be reporting its financial results for the third quarter of their 2019 fiscal year prior to the opening of American markets on May 7th, followed by a conference call at … [Read more...] about INVESTOR ALERT: Array Biopharma Earnings
On Wednesday, May 8th, Eyepoint Pharmaceuticals (EYPT) will be releasing its commercial and financial updates for the 1st quarter of 2019. Eyepoint is a commercial-stage specialty pharmaceuticals … [Read more...] about Earnings Alert: Eyepoint Pharmaceuticals and Alimera Sciences
The American Academy of Neurology (AAN) annual meeting kicks off this weekend, and runs May 4th through the 10th. In March, TG Therapeutics (TGTX) announced the presentation of data from its ongoing … [Read more...] about Three Things to Know Going Into TG Therapeutic’s AAN Presentation
Amarin PLC (AMRN) plans to announce its first quarter 2019 financial results and provide an operational update prior to opening of American markets on Wednesday May 1st at 7:30 ET. I am eagerly … [Read more...] about INVESTOR ALERT: Amarin Earnings
Last Thursday, April 18th, Mustang Bio (MBIO) exploded for a whopping 84% gain despite closing well off its daily high. This move was in response to news that St. Jude Children's Research Hospital … [Read more...] about Will Mustang Bio Run?
Ionis Pharmaceuticals (IONS) has been pushing all-time-highs, which was sparked by a very positive full year 2018 earning report and business update at the end of February. Last week, shares sold off … [Read more...] about INVESTOR ALERT: Upcoming Earnings and Catalyst